RotaTeq

RotaTeq

vaccine, rotavirus

Manufacturer:

Merck Sharp & Dohme
Concise Prescribing Info
Contents
Live, oral pentavalent rotavirus vaccine
Indications/Uses
Prevention of rotavirus gastroenteritis in infant caused by the serotypes G1, G2, G3, G4 & G-serotypes that contain P1A[8] eg, G9.
Dosage/Direction for Use
Vaccination series: 3 doses administered orally to infants, w/ the 1st dose administered at 6-12 wk of age & the subsequent doses at min of 4-wk intervals.
Administration
May be taken with or without food.
Contraindications
Hypersensitivity. Previous history of intussuception.
Special Precautions
Administration via inj. Immunocompromised patients eg, individuals w/ malignancies or who are otherwise immunocompromised, or those receiving immunosuppressive therapy; HIV infection; recipient of blood transfusion or blood products including Ig w/in 42 days; infants w/ active GI illness, chronic diarrhea or growth retardation or history of congenital abdominal disorders or intussusception; acute infection or febrile illness. Infant <6 wk.
Adverse Reactions
ATC Classification
J07BH01 - rota virus, live attenuated ; Belongs to the class of rota virus diarrhea viral vaccines.
Presentation/Packing
Form
RotaTeq vaccine (oral)
Packing/Price
(pre-filled dosing tube) 2 mL x 1's;2 mL x 10 × 1's
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in